MAPT and Cognitive impairment: In addition, passive immunization with the HJ8.5 anti-tau mAB in transgenic mice expressing human P301S tau (P301S-tg) decreased tau-associated pathology, slowed disease progression, and improved cognitive deficits [17–19].